Gemcitabine and Doxetaxel for Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Clinical Trial Alberts, Steven R. , Reid, Joel M. , Morlan, Bruce W. , Farr, Gist H. ... - - Am. J. Clin. Oncol. - 2012 Manuscript - Primary - Primary - GI - N0041
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study Galanis, Evanthia , Jaeckle, Kurt A. , Maurer, Matthew J. ... - - J Clin Oncol - 2009 Manuscript - Primary - Primary - Neuro-Onc - N047B
Alliance A011203: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer Goetz, Matthew P. , Suman, Vera J , Reid, Joel M. , Kuffel, Mary ... - SABCS - Cancer Res - 2020 Abstract - Primary - Primary - Breast - A011203
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results Santisteban, Marta , Buckner, Jan C. , Reid, Joel M. , Wu, Wenting ... - - J Neurooncol - 2009 Manuscript - Primary - Primary - Neuro-Onc - NCCTG-96-72-51